Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079125 | SCV000110994 | uncertain significance | not provided | 2013-03-12 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000194650 | SCV000248761 | uncertain significance | not specified | 2014-01-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080167 | SCV000659798 | benign | RYR1-related disorder | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001266699 | SCV001444876 | benign | Inborn genetic diseases | 2019-06-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079125 | SCV001831769 | benign | not provided | 2018-04-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30611313, 28326467, 27663056, 26972305, 23476141, 23628358, 23394784, 19807743, 19191329) |
Ce |
RCV000079125 | SCV004042051 | benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | RYR1: BS1, BS2 |
Laboratory for Molecular Medicine, |
RCV000194650 | SCV004848599 | benign | not specified | 2021-11-05 | criteria provided, single submitter | clinical testing | The p.Ala4290_Ala4291insThrAlaAla variant in RYR1 is classified as benign because it has been identified in 2.53% (205/8116) of African/African-American chromosomes, including 3 homozygotes, by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA |
Prevention |
RCV001080167 | SCV000852319 | likely benign | RYR1-related disorder | 2021-11-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |